Phase Shift Ventures invests in Florida healthcare robotics startup Rovex Technologies. October 8, 2026 Phase Shift Ventures, an Orlando-based early-stage venture capital firm, has invested in Rovex Technologies, a Gainesville, Florida-based healthcare robotics company developing autonomous systems to improve hospital transportation and operational efficiency. The investment expands Phase Shift's portfolio into healthcare robotics as it continues backing deep technology companies addressing infrastructure and workforce challenges across critical industries. Founded in 2024, Rovex Technologies is developing Rovi, an autonomous transport robot designed to move hospital beds, stretchers and medical equipment through existing healthcare facilities. The technology aims to reduce the manual workload associated with patient and equipment transportation while helping hospitals manage operational demands and staffing constraints. The financial terms of the investment were not disclosed. Rovi combines autonomous navigation, computer vision and a proprietary attachment system that allows the robot to transport existing hospital assets without requiring modifications to beds, stretchers or other equipment. The system is designed to navigate hallways, doorways and elevators within operating healthcare facilities. Before deployment, Rovex creates a digital twin of each hospital, providing a virtual model of the facility to support the robot's navigation and integration into existing workflows. This approach is intended to simplify implementation while limiting the need for changes to hospital infrastructure. The company's technology addresses a labor-intensive component of hospital operations. Moving patients, beds and equipment between departments requires personnel and coordination, making transportation an important consideration for healthcare systems seeking to improve efficiency without compromising patient care. Rovex was co-founded by David Crabb, M.D., an emergency physician, and Benjamin Lok, Ph.D., an experienced healthcare technology entrepreneur. Crabb identified transportation challenges while practicing at nine hospitals and emergency departments across three states. His clinical experience helped shape the company's focus on the operational demands of moving patients and equipment within healthcare facilities. Lok previously co-founded Shadow Health, a healthcare technology company that was subsequently acquired. His background in healthcare technology development complements Crabb's clinical experience as Rovex works to commercialize its autonomous transportation system. Dennis R. Pape, Ph.D., Founder and Managing Partner of Phase Shift Ventures, cited the company's leadership, engineering capabilities and early technology validation as key factors behind the investment. "What attracted us to Rovex was the strength of the team, the technical differentiation of its approach, and the early validation of its technology in hospital environments," Pape said. "Rovex is an engineering-intensive company applying autonomous robotics to a consequential real-world problem." The investment reflects Phase Shift's strategy of identifying early-stage companies developing technologies with practical applications in complex operating environments. Rather than focusing exclusively on software-based artificial intelligence, Rovex is applying AI to physical tasks that require interaction with existing infrastructure. Crabb said the opportunity for autonomous robotics in healthcare extends beyond conventional AI software applications, particularly as hospitals face continued pressure to manage staffing and operational capacity. "There's no shortage of AI companies building software. Far fewer are taking on the physical work that keeps a hospital running," Crabb said. He added that Phase Shift's understanding of both robotics engineering and hospital operations made the firm a suitable investment partner as Rovex works to introduce Rovi to additional health systems. For Phase Shift Ventures, the transaction broadens its investment exposure beyond its existing focus areas of advanced manufacturing, defense technology, space infrastructure and advanced energy. The firm primarily invests in pre-seed and seed-stage companies across Florida and the Southeast, targeting businesses developing technologies for industries with significant technical and infrastructure requirements. Its investment areas include aerospace and defense, autonomous systems, robotics, artificial intelligence, advanced materials, electronics, photonics and cybersecurity. Rovex adds healthcare automation to that portfolio, providing exposure to a market where robotics could help hospitals improve internal logistics and allocate personnel more efficiently. The investment also supports Rovex's efforts to expand adoption of its technology among healthcare providers. Its ability to work with existing hospital beds, stretchers and infrastructure could be an important consideration for facilities evaluating automation without undertaking extensive equipment replacement or building modifications. As Rovex advances Rovi toward broader deployment, its growth will depend on translating early hospital validation into repeatable implementations across different healthcare environments. The investment positions Phase Shift Ventures to participate in the development of autonomous hospital logistics while providing Rovex with an early-stage capital partner focused on commercializing engineering-intensive technologies.

Phase Shift Ventures has invested in Rovex Technologies, a Florida-based healthcare robotics company developing autonomous transport robots for hospitals. Rovex's product, Rovi, uses autonomous navigation, computer vision, and a proprietary attachment system to move beds, stretchers, and equipment through hospital environments without requiring modifications to existing assets. The company was cofounded by David Crabb, an emergency physician, and Benjamin Lok, who previously cofounded and exited Shadow Health. Rovex models each facility with a digital twin before deployment and is currently piloting its system at BayCare Health System's Morton Plant Hospital in Clearwater, Florida. The investment expands Phase Shift Ventures' deep tech portfolio into physical AI and autonomous robotics for healthcare, alongside existing investments in advanced manufacturing, defence technology, and space infrastructure.